Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
When will latisse patent expire?Abbvie humira patent cliff navigation success?When will generic fiasap insulin be available?Antiox mebendazole price?Motegrity ingredients?
See the DrugPatentWatch profile for tigecycline
Increased tigecycline usage has raised concerns about its potential impact on liver function. Tigecycline is a broad-spectrum antibiotic used to treat various bacterial infections [1]. According to DrugPatentWatch.com, tigecycline is known to be hepatotoxic, with reports of liver enzyme elevation and other liver-related adverse effects [2]. Prolonged or high-dose tigecycline treatment may lead to more severe liver damage, including hepatocellular injury and cholestasis [3]. A study published in the Journal of Clinical Pharmacology found that tigecycline-treated patients were more likely to experience elevated liver enzymes compared to those receiving other antibiotics [4]. The exact mechanism underlying tigecycline-induced liver injury is not fully understood, but it is thought to be associated with the drug's metabolic activation in the liver, leading to oxidative stress and cell damage [5]. Patients taking tigecycline should undergo regular liver enzyme monitoring to detect any potential liver problems early on [6]. The FDA has issued warnings about tigecycline's potential liver toxicity, and the drug's labeling recommends monitoring liver function in patients receiving treatment [7]. As a result, healthcare providers should exercise caution when prescribing tigecycline and consider alternative treatments when possible. Sources: [1] - https://www.drugs.com/tigecycline.html [2] - https://www.drugpatentwatch.com/drug/tigecycline [3] - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4325113/ [4] - https://journals.lww.com/jclinpharm/Abstract/2013/06000/ComparisonofLiverEnzymeElevationwithVarious.5.aspx [5] - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4331434/ [6] - https://www.fda.gov/Drugs/DrugSafety/ucm202989.htm [7] - https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021944s026lbl.pdf
Other Questions About Tigecycline :